A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

BACKGROUND: Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (Monofer®) and oral iron in NDD-CKD patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nephrol Dial Transplant
Autors principals: Kalra, Philip A., Bhandari, Sunil, Saxena, Sanjiv, Agarwal, Dhananjai, Wirtz, Georg, Kletzmayr, Josef, Thomsen, Lars L., Coyne, Daniel W.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
CLINICAL SCIENCE
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4805129/
https://ncbi.nlm.nih.gov/pubmed/26250435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv293
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars